Table 2.

Effect of intervention on inflammation markers according to milk consumption

	Before intervention	After intervention	p-value*	Changes	p-value*
Serum 25(OH)D (ng/mL)
Intervention	14.08 ± 5.15	19.1 ± 5.69	< 0.001	5.02	< 0.001
Control	14.1 ± 5.04	13.89 ± 5.85	0.71	0.21
hs-CRP (mg/L)
Intervention	1.1 (0–3.25)	1.15 (0.4–2.92)	0.16	− 0.25	0.77
Control	1.15 (0.1–3.75)	1.4 (0.5–4.2)	0.75	0.25
WBC (billion cells/L)
Intervention	6.56 ± 1.57	6.35 ± 1.68	0.099	− 0.05	0.37
Control	6.64 ± 1.5	6.57 ± 1.35	0.64	0.07
Neutrophil (percent)				7.37
Intervention	61.75 ± 6.57	54.38 ± 5.44	< 0.001	1.06	0.5
Control	58.8 ± 6.97	57.74 ± 6.22	0.12
Lymphocyte (percent)				0.45
Intervention	35.97 ± 7.2	35.52 ± 7.19	0.5	− 0.29	0.75
Control	35.45 ± 6.97	35.74 ± 6.42	0.58
Platelets (billion/L)
Intervention	267.96 ± 35.01	214.82 ± 36.77	< 0.001	53.14	0.49
Control	251.88 ± 56.33	236.42 ± 47.96	0.001	15.46
RDW (percent)
Intervention	13.24 ± 0.78	11.61 ± 0.97	< 0.001	1.63	0.089
Control	13.12 ± 0.83	13.29 ± 1.03	0.066	− 0.17
NLR
Intervention	1.81 ± 0.51	1.62 ± 0.51	< 0.001	0.19	0.39
Control	1.76 ± 0.56	1.68 ± 0.45	0.1	0.08
PLR
Intervention	7.78 ± 2.12	6.35 ± 1.98	< 0.001	1.43	0.48
Control	7.44 ± 2.64	6.88 ± 2.25	0.004	0.56
RPR
Intervention	0.055 ± 0.1	0.05 ± 0.007	< 0.001	0.005	0.98
Control	0.058 ± 0.01	0.054 ± 0.013	0.003	0.004

*Data are expressed as mean ± standard deviation and were tested by ANOVA test